Elizabeth Ann Olmsted

Title: Elizabeth Ann Olmsted: Innovator in Osteoblast Research

Introduction

Elizabeth Ann Olmsted is a notable inventor based in Devon, PA (US). She has made significant contributions to the field of biomedical research, particularly in the study of bone metabolism. Her work has implications for understanding and treating various bone-related disorders.

Latest Patents

Olmsted holds a patent for the osteoblast-testicular protein tyrosine phosphatase. This previously undiscovered transmembrane protein tyrosine phosphatase, expressed only in bone and testis, has been identified, cloned, sequenced, expressed, and subjected to enzymatic analysis. A truncated osteoblast-specific form containing the OST-PTP receptor but lacking the catalytic domain was also identified and characterized. The unique expression pattern of OST-PTP and OST during osteogenesis allows for assays that can screen for abnormal bone growth patterns and metabolic bone diseases. This novel protein serves as a specific target for conventional and gene therapies aimed at treating osteoporosis, osteopetrosis, and other bone metabolic disorders.

Career Highlights

Throughout her career, Olmsted has worked with prestigious institutions, including the University of Michigan and American Home Products Corporation. Her research has contributed to advancements in the understanding of bone metabolism and potential therapeutic targets.

Collaborations

Some of her notable coworkers include Laura Jeanne Mauro and Alan R. Davis. Their collaborative efforts have furthered research in the field of osteoblast function and bone health.

Conclusion

Elizabeth Ann Olmsted's innovative work in identifying and characterizing osteoblast-testicular protein tyrosine phosphatase has opened new avenues for research and treatment in bone metabolic disorders. Her contributions continue to impact the scientific community and pave the way for future advancements in bone health.